Quantcast

Latest Interventional cardiology Stories

2014-08-06 16:29:25

PLEASANTON, Calif., Aug. 6, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today that it has entered into a $30 million Accelerated Share Repurchase (ASR) agreement. "This commitment to capital deployment reflects our ongoing conviction in the long term opportunities in our business," said Gary F. Burbach, President and Chief Executive Officer....

2014-08-06 16:29:23

PLEASANTON, Calif., Aug. 6, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support therapies to save, support and restore failing hearts, announced today that its CE Mark Clinical Trial for HeartMate PHP(TM) (Percutaneous Heart Pump) has commenced. "We are excited to begin the CE Mark Clinical Trial for HeartMate PHP and look forward to successful execution of this important clinical study," said Gary F. Burbach, President and...

2014-08-05 16:27:39

Nation's highest regarded peer-review doctor rating service rates Jamnadas as one of Central Florida's top Interventional Cardiologists ORLANDO, Fla., Aug. 5, 2014 /PRNewswire/ -- Cardiovascular Interventions, a cardiac state-of-the-art facility, is excited to share that its founding physician - Dr. Pradip Jamnadas - received recognition as a "Top Doc" in Central Florida by Castle Connolly Medical Ltd. This highly regarded peer-reviewed doctor rating service has spent nearly 25 years...

2014-08-05 08:35:27

FRAMINGHAM, Mass., Aug. 5, 2014 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Canaccord Genuity 34th Annual Growth Conference at 9:00 a.m. EDT on Thursday, August 14, 2014. The conference is being held August 13-14 at the InterContinental Boston. A...

2014-08-04 16:27:06

PLEASANTON, Calif., Aug. 4, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in the Canaccord Genuity 34(th) Annual Growth Conference on Wednesday, August 13. Taylor C. Harris, Vice President and Chief Financial Officer, will provide an update on the company, beginning at 2:00 p.m., Eastern Daylight Time (11:00 a.m., Pacific...

2014-08-04 12:26:09

LONDON, Aug. 4, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Peripheral Vascular Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018 http://www.reportbuyer.com/pharma_healthcare/medical_devices/peripheral_vascular_devices_emerging_markets_brazil_russia_india_china_south_africa_south_korea_2009_2015.html Global Market Watch: BRICSS Peripheral Vascular Devices sector forecasts to reach at US$732 million by 2016....

2014-08-04 08:29:13

FRAMINGHAM, Mass., Aug. 4, 2014 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced the appointment of Katrin Leadley, M.D., as Chief Medical Officer of HeartWare, effective September 1, 2014. Leadley brings to HeartWare extensive strategic leadership, with more than 20 years of clinical and industry experience...

2014-07-22 12:28:16

Although Procedure Volume Expansion Is Faster Than Other Developed Markets, This Will Be Largely Offset By Price Declines, According to Findings from Decision Resources Group BURLINGTON, Mass., July 22, 2014 /PRNewswire/ -- Decision Resources Group finds that the market for interventional cardiology (IC) devices in Canada will remain relatively stagnant at a value of around $80 million through 2022. This is despite the fact that percutaneous coronary intervention (PCI) volumes are growing...

2014-07-21 16:26:19

PLEASANTON, Calif., July 21, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it will report its operating results for the second quarter of fiscal year 2014 on Wednesday, August 6. The company will hold a conference call to discuss its financial results and operating activities, open to all interested parties, at 1:30 p.m., Pacific...

2014-07-21 16:26:15

Advanced Bare-Metal Stent Provides Additional Treatment Option for Interventional Cardiologists and Patients MARLBOROUGH, Mass., July 21, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has received FDA approval for the REBEL(TM) Platinum Chromium Coronary Stent System, the company's latest generation bare-metal stent for the treatment of coronary artery disease (CAD). Bare-metal stents continue to play an important role in the treatment of CAD and represent a...


Latest Interventional cardiology Reference Libraries

Coronary Angiography
2013-07-29 11:05:01

A coronary angiography, also known as a coronary catheterization, is a procedure that gives both visual and tactical access to coronary circulation and blood filled chambers of the heart for both diagnostic and interventional purposes. It is one of many diagnostic tests used in cardiology. More specifically, coronary catheterization recognizes occlusion, stenosis, thrombosis or aneurismal enlargement of the walls of the coronary arteries; heart chamber size; heart muscle contraction...

More Articles (1 articles) »
Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related